Preclinical Development of a Novel Precision Olfactory Delivery (POD®) - L-dopa Drug-Device Combination Product for the Treatment of OFF Episodes in Parkinson’s Disease (P2.8-049)
Year: 2019
Type: article
Source: Neurology
Authors: Kelsey Satterly, Greg Davies, Bhavin Gajera, Jennifer Wright, Hong Lin, Shweta Muppaneni, Khang To, Inna Dashevsky, Stephen Shrewsbury, John Hoekman
Institution: Impel Neuropharma (United States)
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3159920221
